November 30, 2004
KALYPSYS TO PROVIDE LOS ALAMOS NATIONAL LABRATORY WITH ENABLING PROTEIN EXPRESSION AND PURIFICATION TECHNOLOGIES
September 14, 2004
GENOSPECTRA ANNOUNCES $16.4 MILLION SERIES C FINANCING: NEW FUNDS EXTEND GENE EXPRESSION AND CELL-BASED ASSAY TECHNOLOGIES
August 26, 2004
NEOGENESIS PHARMACEUTICALS ANNOUNCES DRUG DISCOVERY COLLABORATION WITH ACHAOGEN
August 4, 2004
KALYPSYS RAISES $29 MILLION IN SERIES B FINANCING
June 9, 2004
NIH SELECTS KALYPSYS TO PROVIDE ENABLING TECHNOLOGY FOR THE MAJOR INITIATIVE TO FOLLOW THE HUMAN GENOME PROJECT
June 7, 2004
SYMYX THERAPEUTICS CHANGES NAME TO ILYPSA
June 2, 2004
KALOBIOS PHARMACEUTICALS IN-LICENSES ANTIBODY FROM UCSF TO PREVENT AND TREAT PSEUDOMONAS INFECTIONS
May 10, 2004
FORBES MAGAZINE FEATURE ARTICLE: ALEXZA MOLECULAR DELIVERY CORP
January 12, 2004
KALOBIOS AND CELSCIA THERAPEUTICS ANNOUNCE
